U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C32H38F2N2O5S2
Molecular Weight 632.781
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZD-5672

SMILES

CCN(C1CCN(CC[C@H](C2=CC=C(C=C2)S(C)(=O)=O)C3=CC(F)=CC(F)=C3)CC1)C(=O)CC4=CC=C(C=C4)S(C)(=O)=O

InChI

InChIKey=SCXSQUUTGCWHFU-WJOKGBTCSA-N
InChI=1S/C32H38F2N2O5S2/c1-4-36(32(37)19-23-5-9-29(10-6-23)42(2,38)39)28-13-16-35(17-14-28)18-15-31(25-20-26(33)22-27(34)21-25)24-7-11-30(12-8-24)43(3,40)41/h5-12,20-22,28,31H,4,13-19H2,1-3H3/t31-/m1/s1

HIDE SMILES / InChI

Molecular Formula C32H38F2N2O5S2
Molecular Weight 632.781
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

AZD5672 was developed by AstraZeneca for the treatment of rheumatoid arthritis. It was found that the drug inhibits P-glycoprotein and is a CCR5 antagonist. Exists hypothesis that inhibition of CCR5 can bring benefits in the treatment of rheumatoid arthritis. In July 2009, Phase-II for Rheumatoid arthritis was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis.
2012-02-15
Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.
2006-03
Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
2001-05

Sample Use Guides

20-150 mg once daily
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:57:23 GMT 2025
Edited
by admin
on Mon Mar 31 19:57:23 GMT 2025
Record UNII
61XQN688TW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZD5672
Preferred Name English
AZD-5672
Common Name English
BENZENEACETAMIDE, N-(1-((3R)-3-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULFONYL)PHENYL)PROPYL)-4-PIPERIDINYL)-N-ETHYL-4-(METHYLSULFONYL)-
Systematic Name English
Code System Code Type Description
CAS
780750-65-4
Created by admin on Mon Mar 31 19:57:23 GMT 2025 , Edited by admin on Mon Mar 31 19:57:23 GMT 2025
PRIMARY
DRUG BANK
DB11804
Created by admin on Mon Mar 31 19:57:23 GMT 2025 , Edited by admin on Mon Mar 31 19:57:23 GMT 2025
PRIMARY
FDA UNII
61XQN688TW
Created by admin on Mon Mar 31 19:57:23 GMT 2025 , Edited by admin on Mon Mar 31 19:57:23 GMT 2025
PRIMARY
ChEMBL
CHEMBL1951914
Created by admin on Mon Mar 31 19:57:23 GMT 2025 , Edited by admin on Mon Mar 31 19:57:23 GMT 2025
PRIMARY
SMS_ID
100000175721
Created by admin on Mon Mar 31 19:57:23 GMT 2025 , Edited by admin on Mon Mar 31 19:57:23 GMT 2025
PRIMARY
PUBCHEM
16007088
Created by admin on Mon Mar 31 19:57:23 GMT 2025 , Edited by admin on Mon Mar 31 19:57:23 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Did not reported any cardiovascular risk, but it was failed because of unclear reasons in a phase IIb study for rheumatoid arthritis.
Ki
Related Record Type Details
ACTIVE MOIETY